Skip to main content
All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for CMC PHARMACEUTICALS · Developing new and better drug formulations.

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 18, 2025
Income
$40,000.00
What the client paid this registrant for the period.
Client based in
Ohio

Official filing document

 Government bodies contacted 4
  • Defense, Dept of (DOD)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 3
Budget/Appropriations

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection funding.

Defense

Issues related to the FY26 National Defense Authorization Act and Defense Appropriations.

Government Issues

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem